Who owns Verastem, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of VSTM from SEC Form 13F filings across 162 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 162 institutions disclosed 88.4M shares of Verastem, Inc. worth $713.3M — about 87.3% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
162
13F holders
$713.3M
value, 2026 filers
87.3%
of shares outstanding (88.4M sh)
36
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of VSTM's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 9.5M | $76.6M | 0.0% | 9.4% | +3.5% |
| 2 | RTW INVESTMENTS, LP | 6.7M | $54.1M | 0.5% | 6.6% | +1.2% |
| 3 | Deep Track Capital, LP | 5.7M | $46.2M | 0.8% | 5.7% | 0.0% |
| 4 | ARMISTICE CAPITAL, LLC | 5.7M | $46.1M | 0.6% | 5.7% | -18.5% |
| 5 | Rosalind Advisors, Inc. | 4.2M | $34.1M | 10.9% | 4.2% | +6.3% |
| 6 | STATE STREET CORP | 4.0M | $32.4M | 0.0% | 4% | -21.7% |
| 7 | MPM BIOIMPACT LLCNEW | 3.9M | $31.0M | 2.3% | 3.8% | new |
| 8 | VANGUARD CAPITAL MANAGEMENT LLC | 3.8M | $30.7M | 0.0% | 3.8% | -0.8% |
| 9 | Foresite Capital Management VI LLC | 3.1M | $25.3M | 4.5% | 3.1% | 0.0% |
| 10 | Stonepine Capital Management, LLC | 3.0M | $24.5M | 15.4% | 3% | -9.2% |
| 11 | Opaleye Management Inc. | 2.8M | $22.2M | 2.5% | 2.7% | +53.0% |
| 12 | VANGUARD PORTFOLIO MANAGEMENT LLC | 2.6M | $20.6M | 0.0% | 2.5% | -21.8% |
| 13 | Balyasny Asset Management L.P. | 2.3M | $18.5M | 0.0% | 2.3% | +36.3% |
| 14 | GEODE CAPITAL MANAGEMENT, LLC | 2.2M | $17.6M | 0.0% | 2.2% | +5.3% |
| 15 | MORGAN STANLEY | 1.9M | $15.4M | 0.0% | 1.9% | +167.9% |
| 16 | Nantahala Capital Management, LLC | 1.8M | $14.3M | 0.5% | 1.8% | -50.4% |
| 17 | ACORN CAPITAL ADVISORS, LLC | 1.5M | $11.8M | 3.2% | 1.5% | 0.0% |
| 18 | GOLDMAN SACHS GROUP INC | 1.4M | $11.6M | 0.0% | 1.4% | -47.0% |
| 19 | Alyeska Investment Group, L.P. | 1.2M | $9.9M | 0.0% | 1.2% | -46.5% |
| 20 | AIGH Capital Management LLC | 1.1M | $9.0M | 0.9% | 1.1% | -41.8% |
| 21 | FRANKLIN TEMPLETON INC | 1.1M | $10.9M | 0.0% | 1.1% | +0.1% |
| 22 | NEXTBio Capital Management LP | 906,742 | $7.3M | 3.1% | 0.9% | -30.6% |
| 23 | Point72 Asset Management, L.P.NEW | 901,995 | $7.3M | 0.0% | 0.9% | new |
| 24 | BANK OF AMERICA CORP /DE/ | 849,889 | $6.8M | 0.0% | 0.8% | -4.5% |
| 25 | FMR LLC | 842,128 | $6.8M | 0.0% | 0.8% | +34.5% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.